Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia

NCT03389724 is registered in ClinicalTrials.gov with Children's Cancer Hospital Egypt 57357 as lead sponsor.

NCT NCT03389724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03389724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
Lead sponsor
Children's Cancer Hospital Egypt 57357
Phase
Phase 3
Overall status
Completed
Start date
November 14, 2017
Completion date
November 1, 2021
Enrollment
245 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia in children, bone tumor, cardiotoxicity